What it's for (Indications)
- Lornoxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for the symptomatic treatment of mild to moderately severe pain, such as acute pain arising from various origins including musculoskeletal injuries, dental procedures, and postoperative pain.
- Furthermore, it is prescribed for the symptomatic treatment of pain and inflammation associated with inflammatory rheumatic diseases, including but not limited to osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
- Its analgesic and anti-inflammatory properties make it a suitable option for managing chronic pain conditions where inflammation plays a significant role, aiming to improve functional capacity and quality of life for affected patients.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The recommended oral dosage of lornoxicam generally ranges from 8 mg to 16 mg per day, administered in divided doses. For acute pain management, an initial dose of 8-16 mg may be given, followed by 8 mg once or twice daily, not exceeding a total daily dose of 16 mg. For rheumatic conditions such as osteoarthritis and rheumatoid arthritis, the usual maintenance dose is 8-16 mg daily, typically divided into two doses (e.g., 8 mg twice daily). Dosage adjustments may be necessary in elderly patients, individuals with mild to moderate renal or hepatic impairment, or those at increased risk of gastrointestinal adverse events; in such cases, the lowest effective dose should be used for the shortest possible duration. It is crucial for patients to adhere strictly to their physician's prescribed regimen. |
Safety & Warnings
Common Side Effects
- Lornoxicam, like other NSAIDs, can cause a range of side effects affecting various organ systems.
- Common adverse reactions frequently involve the gastrointestinal tract and may include nausea, dyspepsia, abdominal pain, diarrhea, and vomiting.
- More serious gastrointestinal effects, such as peptic ulceration, perforation, or bleeding, can occur, sometimes without warning symptoms.
- Cardiovascular side effects can include hypertension, edema, and a potentially increased risk of thrombotic events.
- Renal adverse effects may manifest as impaired renal function, fluid retention, or acute renal failure, particularly in susceptible individuals.
- Other potential side effects include headache, dizziness, insomnia, skin rashes, and elevated liver enzymes.
- Patients should be advised to report any unusual or severe symptoms to their healthcare provider immediately.
Serious Warnings
- Black Box Warning: **SERIOUS CARDIOVASCULAR AND GASTROINTESTINAL RISKS** Lornoxicam, as a non-steroidal anti-inflammatory drug (NSAID), carries significant risks that warrant careful consideration. **CARDIOVASCULAR THROMBOTIC EVENTS:** NSAIDs, including lornoxicam, increase the risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. Patients with known cardiovascular disease or risk factors for cardiovascular disease may be at greater risk. Lornoxicam is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. **GASTROINTESTINAL RISK:** NSAIDs, including lornoxicam, increase the risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or gastrointestinal bleeding are at greater risk for serious gastrointestinal events.
- Patients receiving lornoxicam should be closely monitored for potential adverse events.
- Particular caution is advised in elderly patients, who are at increased risk for serious gastrointestinal (GI) and renal complications.
- Patients with pre-existing cardiovascular disease, hypertension, or risk factors for cardiovascular events should be carefully evaluated, as NSAIDs can increase the risk of serious thrombotic events.
- Lornoxicam should be used with caution in patients with a history of asthma, as it may exacerbate bronchospasm.
- Close monitoring of renal and hepatic function is essential for patients with pre-existing impairment.
- Fluid retention and edema have been reported; therefore, caution is warranted in patients with heart failure or other conditions predisposed to fluid overload.
- Concomitant use with other NSAIDs, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs) increases the risk of adverse reactions and should be managed carefully.
How it Works (Mechanism of Action)
Lornoxicam exerts its therapeutic effects primarily through the inhibition of cyclooxygenase (COX) enzymes, specifically both COX-1 and COX-2 isoforms, involved in the synthesis of prostaglandins. Prostaglandins are potent mediators of pain, inflammation, and fever. By blocking the activity of these enzymes, lornoxicam reduces the production of prostaglandins, thereby diminishing the inflammatory response, alleviating pain, and reducing fever. While it exhibits inhibition of both isoforms, some studies suggest a relatively balanced inhibition profile or even slight COX-2 selectivity depending on the experimental conditions, which contributes to its anti-inflammatory and analgesic efficacy. This mechanism underlies its utility in managing various pain and inflammatory conditions.